We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ELVAF market cap is 6.51M. The company's latest EPS is CHF -5.9975 and P/E is -0.15.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | 8.93M | 11.6M | 7.54M | 9.88M | 15.54M |
Operating Income | -30.7M | -20.13M | -24.91M | -42.03M | -40.39M |
Net Income | -29.21M | -21.64M | -29.87M | -41.27M | -43.37M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 213.02M | 192.08M | 166.89M | 156.17M | 131.01M |
Total Liabilities | 18.86M | 19.52M | 21.8M | 24.4M | 24.77M |
Total Equity | 194.16M | 172.56M | 145.09M | 131.77M | 106.24M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | -23.61M | -14.16M | -23.36M | -29.79M | -18.88M |
Investing | -12.17M | -5.33M | -5.6M | -4.64M | -1.76M |
Financing | -1M | -920k | 8.86M | 25.72M | 14.77M |
Market Cap | 6.51M |
Price to Earnings Ratio | -0.15 |
Price to Sales Ratio | 0.42 |
Price to Cash Ratio | 1.27 |
Price to Book Ratio | 0.06 |
Dividend Yield | - |
Shares Outstanding | 7.23M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 194 |
52 Week Change | 9.48% |
52 Week High | 1.10 |
52 Week Low | 0.8221 |
Spread (Intraday) | 0 (0%) |
Company Name | Evolva Holding SA (CE) |
Address |
duggingerstra��e 23 reinach 4153 |
Website | https://www.evolva.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions